AGP Picks
View all

AGP Executive Report

Last update: 9 hours ago

Primary Care Safety: Australia’s Monash-led team has added 23 new quality prescribing indicators for adults in primary care, aiming to curb medication harm and guide safer starts, monitoring, high-risk combinations to avoid, and deprescribing. Aging & Dementia Workforce: A government-funded program is inviting aged care staff to join free dementia training, building skills to manage changed behaviours and improve day-to-day dementia support. Healthy Brain Aging: More than 200 seniors gathered to celebrate research linking exercise to brain health, including the role of irisin and a larger hippocampus in people who are more active. Home Care Oversight: Australia’s Department of Health will run a Support at Home payment assurance review, checking whether providers’ care management claims match program rules. Alzheimer’s Delivery Innovation: Curtin researchers are developing a bile-acid nasal spray approach to deliver an Alzheimer’s compound to the brain, funded with $125,000 for early lab and preclinical work. Cancer Progress: The AACR reports U.S. cancer death rates fell 35% from 1991 to 2024, preventing millions of deaths, though gains vary by cancer type. Drug Pricing & Access: In the UK, NICE reversed course on Enhertu after changes to QALY thresholds and a U.S. trade-linked medicines deal, raising the bar for what the NHS will pay per extra year of good quality life. HIV Prevention: Apretude (cabotegravir) remains a key long-acting injectable PrEP option, with approvals spanning dozens of countries. Healthcare Costs: A KFF survey of 25,000+ adults finds high costs and prior authorization are pushing chronically ill people to delay care and skip medications. Iron Deficiency Testing: ASH issued new ferritin cutoffs for diagnosing iron deficiency across ages and pregnancy, even without anemia. Cybersecurity Rule Uncertainty: HHS OCR says the HIPAA Security Rule’s next steps on encryption are still being worked through, leaving covered entities in a holding pattern.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
an hour ago

Ensera, Stevanato Group team up on commercialization services for Alina and Aidaptus platforms

AGP

fallback image
Sep. 16, 2026

ICRAPAIN 2026 wraps in Kolkata with 600+ pain specialists

AGP

fallback image
Sep. 15, 2026

Simvera launches software to model patient support staffing decisions

AGP

fallback image
Jul. 7, 2026

Stellar Bridge Solutions launches consulting firm for smaller pharma companies

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
People Moves: Jones Appointed Marsh Risk US Healthcare Industry Practice Leader; Verisk Names Alling Head of Casualty Solutions

People Moves: Jones Appointed Marsh Risk US Healthcare Industry Practice Leader; Verisk Names Alling Head of Casualty Solutions

Pharmaceutical Industry: Algeria and Oman Explore Ways to Enhance Bilateral Cooperation

Pharmaceutical Industry: Algeria and Oman Explore Ways to Enhance Bilateral Cooperation

PM stresses strengthening Egypt’s pharmaceutical industry, regulatory system

PM stresses strengthening Egypt’s pharmaceutical industry, regulatory system

Beware Kratom: Addictive Gas Station Drug has Friends in High Places

Beware Kratom: Addictive Gas Station Drug has Friends in High Places

As featured in:

@ Journalists!

Join

No journalists yet — this is a new service area. Join today!

Journalists Wanted

fallback image
17 hours ago

Hypertension Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

GlobeNewswire, Inc.

fallback image
Sep. 10, 2026

Pharma Companies Turn to Strategic CDMO Partnerships as Development Needs Evolve

EIN Presswire

fallback image
7 hours ago

Pennsylvania health department announces 2 additional measles deaths, bringing total to 4 

American Hospital Association

fallback image
7 hours ago

CMS announces expansion of ACCESS Model 

American Hospital Association

fallback image
an hour ago

RECORDATI ANNOUNCES THE WINNER OF THE 12TH EDITION OF THE ARRIGO RECORDATI PRIZE FOR SCIENTIFIC RESEARCH

GlobeNewswire, Inc.

fallback image
Sep. 8, 2026

Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Increase in air Pollution Takes a Toll on Your Sleep
Play
Increase in air Pollution Takes a Toll on Your Sleep
YouTube video thumbnail: Criminal Networks Making "Obscene" Profits From Recreational Drugs in Australia, Top Cop Says
Play
Criminal Networks Making "Obscene" Profits From Recreational Drugs in Australia, Top Cop Says
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Intersex Woman Seeks Answers About Irreversible Surgery When She Was a Baby
Play
Intersex Woman Seeks Answers About Irreversible Surgery When She Was a Baby
YouTube video thumbnail: What Should you Know When Using AI for Health-Related Questions?
Play
What Should you Know When Using AI for Health-Related Questions?

Video Title

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.